Opportunity
Simpler Grants.gov #PAR-27-007
NIH Forecast: Clinical Trials and Ancillary Studies within NIH-Funded Clinical Trial Research Networks (UG3/UH3)
Buyer
National Institutes of Health
Posted
October 04, 2023
Respond By
November 10, 2026
Identifier
PAR-27-007
NAICS
541715
This opportunity is a forecasted research grant from the National Institutes of Health (NIH), led by the National Institute of Neurological Disorders and Stroke (NINDS) in partnership with other NIH Institutes and Centers. - The program supports clinical trials and ancillary studies within NIH-funded Clinical Trial Research Networks - Structure: Two-phase (UG3/UH3 cooperative agreement) - Phase 1: Planning and start-up (up to 2 years) - Phase 2: Implementation (up to 5 additional years, contingent on milestones) - No specific products, part numbers, or purchase quantities are listed, as this is a research funding opportunity - No OEMs or vendors are specified - The notice is intended to give applicants time to develop collaborations and projects - Eligible applicants include government entities, nonprofits, educational institutions, businesses, and tribal organizations
Description
The National Institute of Neurological Disorders and Stroke (NINDS), along with other NIH Institutes and Centers, seeks to support projects proposing clinical trials and ancillary studies within NIH-funded Clinical Trial Research Networks. The program encourages multi-center clinical trials within established NIH-funded networks, using a bi-phasic, milestone-driven UG3/UH3 cooperative agreement. Awards initially support a 2-year planning and start-up phase, with possible transition to a 5-year implementation phase. Applications are not currently being solicited; this notice provides time for potential applicants to develop collaborations and projects.